Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
NiveshIQ
NSE: PFIZER · Healthcare
Pfizer Ltd.
₹4,755.10▲ ₹44.40 (+0.94%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on PFIZER. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Pfizer Ltd.
Pfizer Limited is a leading Indian pharmaceutical company that engages in manufacturing, marketing, trading, and distribution of pharmaceutical products. Its key revenue drivers include vaccines, injectables, and anti-infectives. The company has reported an 8% revenue growth with Rs. 204.5 crore net profit in Q1 FY27. Pfizer's strong product portfolio and distribution network have enabled it to maintain a competitive position in the Indian pharmaceutical market. The company's recent developments, including its Q1 FY27 results, indicate a positive growth outlook. With a revenue of ₹2520 Cr and net income of ₹722 Cr, Pfizer Limited is well-positioned for future growth. The company's strong equity and expanding margins are expected to drive its future performance.
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,193 Cr -9.50% | ₹2,281 Cr +4.00% | ₹2,520 Cr +10.50% |
| EBITDA Margin | 37.57% | 56.10% | 43.34% |
| Net Profit | ₹551.33 Cr -11.60% | ₹767.60 Cr +39.20% | ₹722.43 Cr -5.90% |
| EPS | ₹120.51 | ₹62.50 | ₹157.92 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Pfizer Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
Pfizer India reports 8% revenue growth with Rs. 204.5 crore net profit in Q1 FY27
🔒
+ 3 more stories about Pfizer Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹653 Cr, PAT ₹204 Cr, EPS ₹44.69, EBITDA margin 44.8%. Growth context: revenue QoQ +3.8%, PAT QoQ +2.3%. Street verdict: inline, revenue surprise +1.4%, PAT surprise -1.1%.
Product launches, approvals, and therapy-mix improvement are expected to drive the next leg of growth, with execution on...
FY26 (last completed FY): revenue ₹2, 520 Cr, PAT ₹722 Cr, EBITDA margin 43.3%, EPS ₹157.92. Year-on-year: revenue YoY +...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for PFIZER
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track PFIZER alongside your other holdings
Unlock full PFIZER research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Pfizer Ltd.?
NiveshIQ detects active intelligence signals for Pfizer Ltd. (PFIZER) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Pfizer Ltd.?
Pfizer Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,266,663.0L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.